Lipitor Lawsuits Move Forward, as Judge Prepares to Select Cases for Bellwether Trials, Bernstein Liebhard LLP Reports

Share Article

The Firm is representing Lipitor lawsuit plaintiffs who allegedly developed Type 2diabetes due to their use of the statin medication.

Free Case Review
We look forward to the start of bellwether trials, as the outcome of these cases could provide valuable insight into jury decisions in similar Lipitor diabetes claims.

Thousands of Lipitor lawsuits ( filed on behalf of patients who allegedly developed Type2 diabetes due to their use of the statin medication continue to move forward in a the federal multidistrict litigation underway in U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports. According to court documents dated January 22nd, two Lipitor diabetes cases will soon be selected for the proceeding’s first bellwether trials. That same day, the Court issued an Order establishing a Common Benefit Fund for the proceeding. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502)

“Our Firm is representing a number of Lipitor lawsuit plaintiffs who allegedly developed diabetes due to this medication. We look forward to the start of bellwether trials, as the outcome of these cases could provide valuable insight into jury decisions in similar Lipitor diabetes claims,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case reviews to individuals who may have been harmed by Lipitor.

Lipitor Diabetes Litigation
Court documents indicate that more than 2,000 Lipitor diabetes claims are currently pending in the multidistrict litigation underway in South Carolina. Product liability cases involving the cholesterol-lowering medication have been mounting since February 2012, when the U.S. Food & Drug Administration (FDA) announced that the labels for Lipitor and other statins would be updated to include new information about their potential association with Type 2 diabetes. The label change was prompted by the publication of a study in JAMA: Internal Medicine the previous month which suggested that post-menopausal women treated with statins faced an increased risk of developing new-onset Type 2 diabetes. *

According to court documents, all of the Lipitor lawsuits filed in the federal proceeding accuse Pfizer Inc. of endeavoring to protect sales of the drug by concealing its alleged association with diabetes. Plaintiffs also assert that the label modifications made by Pfizer in the wake of the FDA’s 2012 warning still do not sufficiently inform patients about the potential association between Lipitor and diabetes.

Lipitor patients who allegedly developed Type 2 diabetes due to the medication may be entitled to compensation from Pfizer. To learn more about filing a Lipitor lawsuit, please visit Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.

*, JAMA Internal Medicine, January

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have ben able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website